financetom
Business
financetom
/
Business
/
Anterix Hires Morgan Stanley to Conduct Strategic Review; Shares Surge Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Anterix Hires Morgan Stanley to Conduct Strategic Review; Shares Surge Pre-Bell
Feb 11, 2025 5:19 AM

08:02 AM EST, 02/11/2025 (MT Newswires) -- Anterix ( ATEX ) shares were up 14% in Tuesday's premarket session after it said that it hired Morgan Stanley ( MS ) to conduct a strategic review process for the company.

The company said Morgan Stanley ( MS ) will review pricing, payment, and ownership terms along with potential collaborations with strategic partners on additional products and services.

Anterix ( ATEX ) said there is no deadline or timetable for when the strategic review will be completed.

Price: 32.54, Change: +4.02, Percent Change: +14.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Immunovant's Fiscal Q1 Net Loss Widens
Immunovant's Fiscal Q1 Net Loss Widens
Aug 11, 2025
07:29 AM EDT, 08/11/2025 (MT Newswires) -- Immunovant ( IMVT ) reported a fiscal Q1 net loss Monday of $0.71 per diluted share, wider than the net loss of $0.60 a year earlier. Analysts polled by FactSet expected a loss of $0.68. As expected, no revenue for the quarter ended June 30 was reported. As of June 30, the company...
Sionna Therapeutics' Q2 Net Loss Narrows
Sionna Therapeutics' Q2 Net Loss Narrows
Aug 11, 2025
07:27 AM EDT, 08/11/2025 (MT Newswires) -- Sionna Therapeutics ( SION ) reported a Q2 net loss Monday of $0.41 per diluted share, narrowing from its loss of $2.71 a year earlier. Two analysts polled by FactSet expected a loss of $0.65 per share. No revenue was reported for the quarter ended June 30. The company reported cash, cash equivalents...
Apogee Therapeutics Q2 Net Loss Widens
Apogee Therapeutics Q2 Net Loss Widens
Aug 11, 2025
07:28 AM EDT, 08/11/2025 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported Monday a Q2 net loss after tax of $66.1 million, widening from a loss of $33.8 million a year earlier. Analysts polled by FactSet expected a loss of $62.8 million. The company reported no revenue for the quarter ended June 30. Apogee said its cash, cash equivalents,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved